Heliocide B2



Compound IDCDAMM02667
Common nameHeliocide B2
IUPAC name2-hydroxy-3-methoxy-10a-methyl-7-(4-methylpent-3-enyl)-9,10-dioxo-4-propan-2-yl-8,8a-dihydro-5H-anthracene-1-carbaldehyde
Molecular formulaC26H32O5

Experimental data

Retention time6.47
Adduct[M+H]+
Actual mz425.236
Theoretical mz425.232
Error9.7
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.4774

Identifiers and class information

Inchi keyFGQZFAWOAMMXKN-UHFFFAOYNA-N
SmilesO=CC1=C(O)C(OC)=C(C=2C(=O)C3(C)CC=C(CCC=C(C)C)CC3C(=O)C12)C(C)C
SuperclassBenzenoids
ClassAnthracenes

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)424.536
Computed dipole moment(dipole)5.096
Total solvent accessible surface area (SASA)723.932
Hydrophobic component of SASA (FOSA)537.646
Hydrophilic component of SASA (FISA)134.196
Pie component of the SASA (PISA)52.09
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1366.07
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)6.5
Free energy of solvation of dipole (dip^2/V)0.0190091
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.822461
Predicted polarizability in cubic angstroms (QPpolrz)44.519
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.202
Predicted octanol/gas partition coefficient (QPlogPoct)18.214
Predicted water/gas partition coefficient (QPlogPw)7.587
Predicted octanol/water partition coefficient (QPlogPo/w)4.174
Predicted aqueous solubility (QPlogS)-5.393
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.654
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.653
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)528.829
Predicted brain/blood partition coefficient (QPlogBB)-1.181
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)248.477
Predicted skin permeability, log Kp (QPlogKp)-3.137
PM3 calculated ionization potential (IP(ev))9.41
PM3 calculated electron affinity (EA(eV))1.148
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)0.548
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)100.291
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q96KS0EIT6HIF-prolyl hydroxylase 1T53904SwissTargetPrediction
P35462DRD3Dopamine D3 receptorT02551SwissTargetPrediction
O14757CHEK1Serine/threonine-protein kinase Chk1T62449SwissTargetPrediction
P14061HSD17B1Estradiol 17-beta-dehydrogenase 1T44011SwissTargetPrediction
P30291WEE1Serine/threonine-protein kinase WEE1T69991SwissTargetPrediction
P49810PSEN2Gamma-secretaseT99204SwissTargetPrediction
P25024CXCR1Interleukin-8 receptor AT00884SwissTargetPrediction
Q14680MELKMaternal embryonic leucine zipper kinaseT96892SwissTargetPrediction
Q13451FKBP5Peptidyl-prolyl cis-trans isomerase FKBP5T98337SwissTargetPrediction
P06881CALCACalcitonin gene-related peptide 1T93509SwissTargetPrediction
P21757MSR1Macrophage scavenger receptor types I and IIT50007SEA
Q9GZT9EGLN1Egl nine homolog 1T32880SwissTargetPrediction

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T53904DI0010Acute disease anaemia[ICD-11: 3A90]Q96KS0EIT6
T02551DI0051Bipolar disorder[ICD-11: 6A60]P35462DRD3
T02551DI0331Parkinsonism[ICD-11: 8A00]P35462DRD3
T62449DI0027Anal cancer[ICD-11: 2C00]O14757CHEK1
T62449DI0172Head and neck cancer[ICD-11: 2D42]O14757CHEK1
T62449DI0183Hodgkin lymphoma[ICD-11: 2B30]O14757CHEK1
T62449DI0238Lung cancer[ICD-11: 2C25]O14757CHEK1
T62449DI0241Lymphoma[ICD-11: 2A80-2A86]O14757CHEK1
T62449DI0321Ovarian cancer[ICD-11: 2C73]O14757CHEK1
T62449DI0326Pancreatic cancer[ICD-11: 2C10]O14757CHEK1
T62449DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]O14757CHEK1
T69991DI0321Ovarian cancer[ICD-11: 2C73]P30291WEE1
T69991DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P30291WEE1
T69991DI0429Uterine ligament/parametrium/uterine adnexa neoplasm[ICD-11: 2C72]P30291WEE1
T99204DI0320Osteoarthritis[ICD-11: FA00-FA05]P49810PSEN2
T99204DI0380Shoulder lesion[ICD-11: FB53]P49810PSEN2
T99204DI0390Soft tissue disorder[ICD-11: FB56]P49810PSEN2
T00884DI0324Pain[ICD-11: MG30-MG3Z]P25024CXCR1
T96892DI0012Acute myeloid leukaemia[ICD-11: 2A60]Q14680MELK
T96892DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q14680MELK
T96892DI0249Mature B-cell leukaemia[ICD-11: 2A82]Q14680MELK
T96892DI0250Mature B-cell lymphoma[ICD-11: 2A85]Q14680MELK
T96892DI0284Myelodysplastic syndrome[ICD-11: 2A37]Q14680MELK
T96892DI0286Myeloproliferative neoplasm[ICD-11: 2A20]Q14680MELK
T93509DI0163General pain disorder[ICD-11: 8E43]P06881CALCA

Copyright © 2025